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ABSTRACT 
Objective: The objective of the present work was to formulate and characterize nano dispersive gel (NDG) for topical delivery of water-insoluble 
antifungal agent ketoconazole in order to enhance its solubility, penetration through the skin and antifungal activity.  
Methods: Nano dispersion of the drug was first prepared by swollen micelles technique (SMT) using tween 80 and chloroform which is then 
incorporated into the gel using carbopol 934. Ten formulations of ketoconazole loaded NDG was prepared and characterized for different 
physicochemical parameters like homogeneity, pH, spreadability, extrudability, practical yield, drug content, in vitro drug release, ex vivo 
permeation study, and biological parameter antifungal activity. 
Results: The formulated topical preparation exhibit pH in the range of 6.5 to 7.4, and unveiled excellent homogeneity, spreadability and 
extrudability. Out of 10 formulations, formulation F4 showed maximum drug content of 95.56±1.13% and practical yield of 97.23±0.51%. The in 
vitro drug release studies were performed using pH 7.4 phosphate buffer. Formulation F4 showed best in vitro drug release 96.52±0.52% at the end 
of 24 h of study. Ex vivo permeation study of formulation F4 carried out using franz diffusion cell, also manifested good permeation and flux of drug 
across the chicken skin. Antifungal activity test of formulation F4 was carried out by the cup plate method using Aspergillus niger strain against 
marketed ketoconazole unveiled higher antifungal activity than marketed one.  
Conclusion: The study confirmed formulation F4 to be an optimized and promising formulation for the effective treatment of topical fungal 
infections with enhanced solubility and penetration through the skin. 
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Infections are caused by fungus ranges from superficial conditions of 
the skin (e. g., athletes foot and ringworm) and nails (e. g., 
onychomycoses) to the deadly contagious disease [1]. Ringworm 
also called dermatophytosis usually manifest as a series of rapidly 
expanding irritating lesions which can occur in any area of the skin, 
chiefly attack stratum corneum of keratinized tissues and hair fibres 
resulting in autolysis of the fibre structure, breaking off the hair and 
alopecia [2]. 
Ketoconazole is widely used recent synthetic imidazole ring-
containing powerful antifungal agent active against most of the 
species of fungi and yeast. A topical preparation of ketoconazole is 
used for the treatment of infections caused by a wide variety of fungi 
like candida and tinea [3]. In biopharmaceutics classification system 
(BCS), ketoconazole is classified as a class-II drug, based on its 
absorption and dissolution property, since it has a high permeability 
but its solubility in aqueous media is insufficient for the whole dose 
to be dissolved in the gastrointestinal (GIT) fluids under normal 
condition [4]. It is very lipophilic, practically it is insoluble in 
mineral oil (<0.01%), and in solvent with alkaline pH but it is freely 
soluble in most of the organic solvents including chloroform, n-
octanol, ethyl alcohol, methanol, dimethyl sulfoxide (DMSO) [5]. It is 
least stable at pH 1 and most stable at pH 7 [6]. The poor aqueous 
solubility of ketoconazole is the limitation for topical delivery [3].  
Topical drug delivery systems are extensively used for the treatment 
of local skin disorders. Topical application of drugs has potential 
advantages of delivering the drug directly to the site of action for an 
extended period. It bypasses the first pass metabolism, avoids 
problems related to absorption, changes in pH and also avoids risk 
and inconvenience of intravenous (IV) therapy [7, 8]. However, 
stratum corneum the top layer of the epidermis is the major barrier 
of drug penetration through the skin. For transdermal delivery, 
ideally, the drug should have low molecular weight (≤ 500 Da), high 
lipophilicity and effective at low dosage. Considerable attention has 
been focused in the last few decades to develop novel drug delivery 
systems (NDDS), to lower stratum corneum barrier and increase 
permeability [9]. This approach mainly includes electrophoresis, 
iontophoresis, sonophoresis, chemical permeation enhancers, 
microneedles, tape stripping, nanoparticles, nanodispersion [13] 
and vesicular systems including liposomes, niososmes, ethosomes 
and transferosomes [10, 11]. Developed liposomes and niosomes, 
having high permeability, controlled release and target specificity 
but liquid nature of topical liposomes and an aqueous suspension of 
niosomes may have problems associated with physical instability 
such as fusion, aggregation and leaking of the entrapped drug [3, 10, 
12]. Nanodispersion plays an efficient role in the topical delivery of 
poorly aqueous soluble or insoluble drug whereby decrease of 
molecule size to nanoscale measurements leads to a massive 
expansion in the surface area that enables the faster penetration of 
medication through the skin and upgrades the drug bioavailability. 
This is often because of the rise in solubility of the drug on the 
reduction of particle radius. Terribly microscopic particle size 
causes an oversized reduction in gravity force and therefore the 
brownian motion could also be sufficient for overcoming gravity. 
This implies that no deposition happens on storage [13].  
Topical preparations like ointments, creams, lotions are extensively 
used as topical agents have numerous disadvantages. Generally, they 
are very sticky causing discomfort to the patient. Likewise, they also 
increase the contact time [8, 14]. Unlike other topical preparations, 
the gel is non-sticky, does not cause discomfort to the patient. Drug 
release is faster in gel formulation compared with ointments and 
creams. It also has more spreading co-efficient than ointment and 
cream [15, 16]. Hence in the present study attempt has been made to 
formulate and characterize NDG of ketoconazole. NDG is semisolid 
dosage form formed by the combination of nanodispersion and gel. 
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The gelling agent is added in nanodispersion that gives NDG. NDG 
overcomes the limitation of poor aqueous solubility of ketoconazole 
with the advantages of gel. 
MATERIALS AND METHODS 
Ketoconazole was received as a gift sample from Vonstachem Ltd, 
Delhi. Carbopol 934, triethanolamine (TEA), tween 80, chloroform, 
disodium hydrogen phosphate and potassium dihydrogen 
phosphate were provided by Galgotias University, Greater Noida. 
Strains of Aspergillus niger were purchased from the Institute of 
Microbial Technology (IMTECH, Chandigarh, India). All other 
chemicals used were of analytical grade. 
Preparation of nanodispersion of ketoconazole 
Nanodispersion of ketoconazole was prepared by a special 
technique called the formation of SMT [13]. The drug was dissolved 
in sufficient volume of chloroform and then tween 80 were added 
continuously with stirring. After complete addition of tween 80 in 
the final mixture, further stirred for 2 d to provide controlled and 
complete evaporation of chloroform. This leads to the formation of a 
system with ultra-low interfacial tension as well as drug particle size 
in nanoscale. Finally, ample volume of phosphate buffer (pH 6.8) 
was added to give nanodispersion. Formation of viscous mixture 
ensures the complete removal of chloroform. 
Preparation of ketoconazole loaded nano dispersive gel 
Carbopol 934 in required quantity was added to the ketoconazole 
nanodispersion with constant stirring at 500 rpm for 2 h. Speed was 
reduced later to avoid air entrapment. Finally, TEA was added to 
neutralize the mixture and provide appropriate consistency [17]. 
Different formulations were developed by varying tween 80 and 
carbopol 934 concentrations (table 1). 
 
Table 1: Composition of different formulations 
Ingredients F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 
Ketoconazole (%) 2 2 2 2 2 2 2 2 2 2 
Tween 80 (%) 1 1.5 2 2.5 3 3.5 4 4.5 5 5.5 
TEA (ml) 0.5  0.5 0.5  0.5 0.5 0.5  0.5 0.5 0.5 0.5 




Prepared formulations were characterized for different parameters 
including physical appearance and homogeneity, pH determination, 
spreadability, extrudability, percent practical yield, drug content, in 
vitro dissolution, ex-vivo permeation and antifungal activity.  
Physical appearance and homogeneity 
All the NDG formulations containing ketoconazole were visually 
inspected for clarity, homogeneity, colour, presence of particles and 
fibres [18]. Grades were allotted (+++excellent; ++good; +fair). 
Determination of pH 
Digital elico pH meter was used to check the pH of NDG at room 
temperature. At first, the pH meter was calibrated utilizing standard 
buffers of pH 4 and 9.2. Precisely 2.5 g of gel was weighed and 
dispersed in 25 ml of distilled water and after that pH meter was 
plunged in the dispersion and the pH was measured. The pH 
measurement of each formulation was done in a triplicate manner 
and average values were calculated [19]. 
Spreadability study  
For the determination of spreadability [7] of the prepared NDG 
formulations a wooden block was taken which is provided by a 
pulley at one end. Spreadability was determined on the basis of ‘Slip’ 
and ‘Drag’ properties of NDG. A ground glass slide was taken and 
fixed on this block. An excess of NDG (about 2 g) collected and 
applied on this ground slide. The NDG was then embedded between 
this slide and another glass slide having the dimension of the fixed 
ground slide. On the top of the two slides, a 1 kg weight is placed for 
5 min to provide a uniform film of the NDG and to expel air. The top 
plate is then subjected to pull of 80 g. The time required by the top 
slide to cover a distance of 7.5 cm was noted. Spreadability of each 
formulation was done in a triplicate manner and average values 
were calculated by using the formula given below. 
S=M×L÷T 
Where, 
S = Spreadability 
M = Weight tied to upper slide. 
L = Length of glass slides. 
T = Time taken to separate the slides completely from each other.  
Extrudability 
Method of extrudability study [4] of NDG formulation was based 
upon the quantity in the percentage of gel extruded from the tube on 
the application of certain load. More the quantity extruded better 
was extrudability. The NDG was filled in a clean, aluminium 
collapsible 10 g tube with 5 mm opening nasal tip. This tube was 
subsequently placed in between two glass slides and was clamped. A 
constant load of 1 kg was placed on the slides and gels extruded was 
collected and weighed. Extrudability of the gel was then determined 
by weighing the amount of gel extruded through the tip when a load 
was put. The percentage of gel extruded was calculated and grades 
were allotted (+++excellent; ++good; +fair). 
Practical yield (PY) 
PY [4] helps in selection of an appropriate method of preparation. It 
was calculated to know about percent yield and efficiency of the 
preparation method. NDG was collected and weighed to determine 
the PY of each formulation in triplicate manner and average values 
were calculated from following and noted down. 
PY=Practical mass NDG÷Theoretical mass (drug+carrier)×100 
Drug content 
To determine drug content [20], NDG equivalent to 5 mg of model 
drug was taken and dissolved in 5 ml of methanol. The solutions were 
filtered and were further diluted such that the absorbance falls within 
the range of the standard curve. The absorbances of solutions were 
determined at 215.80 nm by UV-visible spectrophotometer. The actual 
drug content of each formulation was estimated using the following 
formula in triplicate manner and average values were noted down.  
% drug content = Actual drug content in weighed quantity of gel/ 
 Theoretical amount of drug in gel × 100 
In vitro dissolution studies 
In vitro release studies of various samples of NDG were carried out 
using biological egg membrane [16]. A fresh chicken egg was carefully 
broken and its outer membrane was removed with necessary 
precautions without tearing/damaging and soaked overnight in the 
dissolution medium [7]. The egg membrane with a surface area of 3.14 
cm2 available for diffusion was mounted on a franz diffusion cell. A 
known amount of NDG was weighed and applied on the membrane 
mounted on franz diffusion cell from the donor side. The receptor 
compartment was filled with 15 ml of phosphate buffer. The 
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temperature was maintained at 37±0.5 °C. The receptor compartment 
was constantly stirred at 100 rpm. Samples from the receptor fluid 
(0.5 ml) were withdrawn at various time intervals (30 min, 1 h, 2 h, 4 
h, 6 h, 8 h, 12 h, 16 h, and 24 h.) and replaced immediately by the fresh 
buffer solution. The samples were then analysed to determine 
absorbance spectrophotometrically using UV-vis spectrophotometer 
(Shimadzu Corporation, Japan 1800) at 215.80 nm. Cumulative 
percent drug release of the various formulation was calculated in 
triplicate manner and average values were noted down [7, 12]. 
Ex vivo permeation study 
To perform ex vivo permeation study [21, 22] of formulation showing 
better release (formulation F4) and marketed formulation (phytoral), 
franz diffusion cell was chosen. The selected franz diffusion cell was 
having effective diffusion area of 3.14 cm2 and cell volume of 15 ml. 
Freshly slaughtered chicken skin [23] was taken from the local slaughter 
house and soaked in sodium bromide solution for 5 h and then washed 
with water in order to remove adhering fat tissue. The outer layer 
(epidermis) was washed thoroughly with water, dried at 25% RH and 
stored in the freezer until further use. Skins were allowed to hydrate for 
1 h before being mounted on the franz diffusion cell. A suitable size of 
chicken skin was cut and mounted in the franz diffusion cell in such a 
way that the dermis faces receiver compartment and stratum corneum 
faces donor compartment. A known amount of formulated gel was 
loaded in the donor compartment. The receptor compartment was filled 
with 15 ml of phosphate buffer pH 7.4. The temperature was maintained 
at 37±0.5 °C. Magnetic beads of suitable size was placed inside the 
receiver and then this assembly was placed on a magnetic stirrer and 
stirred for 24 h. The samples (0.5 ml aliquots) were withdrawn from the 
receptor cell at a regular time interval and were analysed 
spectrophotometrically (Shimadzu Corporation, Japan 1800) at 
wavelength 215.80 nm. Same procedure was repeated for normal 
marketed ketoconazole gel (phytoral). The cumulative amount of drug 
permeate across the skin was determined as a function of time of both 
the samples in triplicate manner and average values were noted down. 
Permeability coefficient and flux were also calculated using the following 
standard formula [5]. 
Permeability coefficient (apparent permeability) 
Papp =  Va/Area ×  time ×  [drug]acceptor/[drug]donor] 
Where, 
 Va = volume in acceptor compartment 
 Area = surface area of the intestinal membrane 
 Time = total transport time 
Flux (J) 
J=Papp×CD 
 where CD = concentration of donor solution. 
Antifungal activity 
“Cup plate method” [9, 22] was opted to determine the antifungal 
activity of optimized formulation F4, in comparison with normal 
marketed ketoconazole gel (phytoral). Fungal strain Aspergillus niger 
as the test microorganism was used. An inoculum of Aspergillus niger 
was spread over the sabouraud's dextrose agar media and allowed to 
solidify in the petri dish. After solidifying the agar plate, cups were 
made with sterile borer (5 mm). By using a sterile syringe, 0.5 ml of 
NDG solution was filled in into one cup and marked with ‘S’ similarly 
0.5 ml of marketed gel solution was filled in another cup and marked 
with ‘M’. This plate then kept for incubation for 24 h at 37 °C 
temperature. After incubation, the zone of inhibition was calculated 
and compared. 
RESULTS AND DISCUSSION  
In the present research work ketoconazole NDG were prepared 
using tween 80 along with carbopol 934 in different proportions by 
the technique called formation of SMT. The prepared ketoconazole 
NDG were characterized for various parameters like homogeneity, 
pH, spreadability, extrudability, practical yield, drug content, in vitro 
drug release, ex vivo permeation study, and biological parameter 
antifungal activity. 
Physical appearance and homogeneity 
Except F9 and F10, all other formulations were having excellent and 
good homogeneity and physical appearance (table 2). Formulations 
were white, viscous, homogeneous free from fibres with a smooth 
and considered acceptable to avoid the risk of irritation upon 
application to the skin. This implies that NDG has better patient 
acceptability than other topical preparations [15, 16]. 
Determination of pH 
pH of all the formulations was between pH 6.5-7.4 (table 2), which 
fall in the normal pH range of the skin [24], which ensures the 
compatibility of the formulation with skin. 
Spreadability  
Spreadability of all the formulations under study was in between 
26.65±1.33 to 33.52±0.88 g. cm/s (table 2), which represents the good 
spreading efficiency of NDG that will meet ideal quantity to the skin [24]. 
Extrudability  
Extrudability is a useful empirical test to measure the forces 
required to extrude out the gel from a tube [25]. In this study out of 
10 formulations prepared and tested except F9 and F10, 
extrudability grade of all the formulations was+++or++(table 2), 
which represent excellent or good extrudability of NDG. 
 
Table 2: Characterization data of different formulations 
Formulations Homogeneity Spreadability (g. cm/s) Extrudability pH 
F1 +++ 32.12±1.26 +++ 6.75±0.46 
F2 +++ 31.11±1.45 ++ 6.50±0.55 
F3 +++ 33.22±0.96 +++ 7.02±0.12 
F4 +++ 33.12±1.32 +++ 6.88±0.32 
F5 ++ 33.52±0.88 ++ 6.85±0.22 
F6 +++ 30.22±1.22 ++ 7.21±0.02 
F7 ++ 29.12±1.25 +++ 6.65±0.26 
F8 ++ 29.21±1.66 +++ 6.52±0.66 
F9 + 27.23±1.54 + 7.21±0.23 
F10 + 26.65±1.33 + 7.13±0.21 
(+++excellent; ++good; +fair); Data expressed in mean±SD, (n=3) 
 
Practical yield (PY) 
Table 3 shows the results of percent practical yield of all the 
formulations. The PY of prepared NDG was found to be in the range 
of 42.65±0.13% to 97.23±0.51%. The maximum yield was found to 
be 97.23±0.51% in F4 formulation. These results indicated that the 
utilized method was efficient and appropriate for the preparation of 
NDG [4]. 
Drug content 
Drug content of all the formulation is shown in table 3. Drug content 
of prepared NDG was in the range of 76.55±0.32% to 95.56±1.13%. 
The maximum drug content was found to be 95.56±1.13% in 
formulation F4. These results indicated the high content uniformity 
of the formulation [18], with the results being within the 
pharmacopeial limits. 
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Table 3: Practical yield and drug content of different formulations 
Formulation  Practical yield (%) Drug content (%) 
F1 92.02±1.25 76.55±0.32 
F2 94.23±0.92 78.65±0.02 
F3 89.32±1.21 80.54±0.52 
F4 97.23±0.51 95.56±1.13 
F5 88.32±1.03 82.58±0.51 
F6 42.65±0.13 90.36±0.12 
F7 78.20±0.65 88.88±0.74 
F8 76.50±1.51 77.55±1.24 
F9 66.50±0.94 83.65±0.08 
F10 75.23±0.65 91.88±0.81 
Data expressed in mean±SD, (n=3) 
 
In vitro dissolution studies 
Cumulative % drug release data of various formulation is shown in 
table 4 and 5. The cumulative % release of the different formulation 
after 24 h of the study was in the range of 28.56±1.06% to 
96.52±0.52% while it was 49.25±1.13% after 24 h for pure drug 
ketoconazole. These data revealed that there was an enhancement in 
dissolution rate from all formulation when compared to pure drug 
ketoconazole. From the cumulative % drug release plot, the 
maximum % release 96.52±0.52%, was shown by formulation F4 
that contain 1% carbopol 934 and 2.5% tween 80. This implies that 
formulation F4 is an optimized formulation [7, 12]. 
 
Table 4: Cumulative % drug release data of pure drug and formulation F1 to F5. 
Time (h) Pure drug F1 F2 F3 F4 F5 
0.5 1.12±1.09 1.54±0.08 1.89±0.05 2.56±0.15 9.44±0.22 5.01±0.15 
1 4.35±1.12 5.62±0.56 7.54±1.12 13.22±0.14 16.64±0.41 9.41±0.58 
2 12.55±1.11 14.55±0.42 17.88±0.21 26.33±1.10 32.41±0.35 22.07±1.05 
4 18.65±0.53 20.54±1.02 25.66±0.24 34.55±0.20 43.92±0.51 32.70±0.95 
6 26.32±1.05 29.33±0.56 34.22±0.42 55.23±1.13 59.39±0.42 51.20±0.24 
8 34.22±1.25 38.23±0.84 45.66±0.41 63.22±0.24 71.53±0.36 58.23±0.89 
12 40.62±0.83 44.32±0.79 52.11±1.32 71.33±0.12 83.10±0.52 68.33±1.23 
16 48.22±1.02 51.46±0.65 60.12±0.35 80.23±0.42 96.60±0.44 79.33±0.52 
24 49.25±1.13 52.23±1.26 60.54±0.25 83.56±0.32 96.52±0.52 80.21±0.55 
Data expressed in mean±SD, (n=3) 
 
Table 5: Cumulative % drug release data of formulation F6 to F10 
Time (h) F6 F7 F8 F9 F10 
0.5 3.45±0.58 2.89±0.21 1.98±0.54 1.20±1.01 0.82±0.62 
1 7.25±0.83 6.55±0.54 6.33±0.65 5.65±0.89 4.56±0.58 
2 15.44±1.21 10.26±1.21 8.33±1.22 8.10±0.65 7.55±0.42 
4 24.65±1.03 18.33±1.11 14.23±1.32 12.22±0.52 10.52±1.22 
6 36.55±1.52 29.36±1.50 25.33±0.25 20.65±1.06 17.25±1.52 
8 48.65±0.89 35.33±0.54 31.22±0.98 28.66±0.84 25.23±1.65 
12 59.22±0.97 44.25±0.98 40.22±0.65 36.55±0.54 31.25±0.95 
16 68.26±1.25 56.22±0.65 45.33±1.51 38.25±1.02 31.25±0.78 
24 69.22±1.22 58.65±1.05 42.51±0.85 36.52±1.21 28.56±1.06 
Data expressed in mean±SD, (n=3) 
 
Ex vivo permeation study  
Table 6 shows the data of cumulative percent drug permeate of 
formulation F4 and marketed formulation (P). The cumulative % 
drug permeate of F4 and P after 24 h of the study was found to be 
89.12±0.63% and 68.86±1.65%. Permeability coefficient of F4 and P 
were found to be 0.0015 cm/min and 0.0012 cm/min respectively. 
The flux of F4 and P were found to be 2.10 µg/cm2/min and 1.69 
µg/cm2/min respectively. From the result it is clear that formulation 
F4 which was showing maximum cumulative % drug release among 
all other formulations also showed good permeation of drug across 
the chicken membrane in comparison to marketed formulation 
(phytoral). It indicates that formulating NDG leads to enhancement 
in permeability of drug [26]. 
 
Table 6: Cumulative % drug permeates data of formulation F4 and marketed formulation phytoral (P). 
Time (h) F4 (%) P (%) 
1 14.56±0.83 7.25±1.48 
2 29.35±1.24 15.44±1.62 
4 39.25±1.21 24.65±1.24 
6 56.25±0.43 36.55±1.08 
8 68.56±0.81 48.65±0.86 
12 80.01±1.05 59.22±1.21 
16 87.25±1.25 68.26±1.07 
24 89.12±0.63 68.86±1.65 
Data expressed in mean±SD, (n=3) 
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Antifungal activity  
Zone of inhibition of ketoconazole loaded NDG (S) and normal 
marketed ketoconazole gel (M) after 24 h of incubation were found 
to be 28.5±0.42 mm and 22.56±2.51 mm respectively. These results 
indicate that antifungal activity shown by prepared ketoconazole 
loaded NDG is more than normally marketed ketoconazole. This is 
due to enhanced permeation and solubility on the reduction of 
particle size to nano measurement [9, 20]. 
CONCLUSION 
The results of these studies showed that, formulating NDG of 
ketoconazole lead to enhancement in solubility and dissolution 
behaviour of poorly soluble antifungal drug ketoconazole. Carbopol 
934 used as a gelling agent that produced a gel with, an excellent 
physical appearance, spreadability and extrudability which proved 
carbopol 934 to be a promising gelling agent to prepare NDG. The 
formation of SMT for preparing nanodispersion was found to be 
satisfactory as it produced a good product with high practical yield 
as well as high drug content. Out of 10 formulations prepared, 
formulation F4 exhibit best drug release, as well as dissolution rate 
when compared to pure drug. Formulation F4 also showed good 
skin permeability and higher antifungal activity than normal 
marketed ketoconazole gel. Practical yield, as well as Drug content of 
formulation F4, was also maximum among all other formulations. 
Henceforth, we concluded that formulation F4 is an optimized and 
promising formulation for effective treatment of topical fungal 
infections with enhanced solubility and penetration through skin 
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